Condition: Non-small Cell Lung Cancer · Sponsor: H. Lee Moffitt Cancer Center and Research Institute
This is a non-registrational, cohort study enrolling eligible Black patients diagnosed with histologically or cytologically, advanced/metastatic NSCLC without known EGFR/ALK/ROS1 tumor mutations, and who are ≥ 18 years of age, ECOG performance status 0-2, and may have detectable ctDNA at baseline.
This description comes directly from the study's public registry record.
Anahid Aminpour · 813-745-0287 · anahid.aminpour@moffitt.org
Always discuss trial participation with your own doctor first.
| Moffitt Cancer Center | Tampa, Florida, United States | Recruiting |
| Johns Hopkins Sidney Kimmel Comprehensive Cancer Center | Baltimore, Maryland, United States | Recruiting |
| TidalHealth Peninsula Regional | Salisbury, Maryland, United States | Recruiting |
| Montefiore Medical Cancer Center | The Bronx, New York, United States | Recruiting |
| Baptist Clinical Research Institute | Memphis, Tennessee, United States | Recruiting |
| Nashville General Hospital | Nashville, Tennessee, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06745882